Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.14% | 129.73 | 0.0% | $1301.61m | |
| OCGN | Ocugen, Inc. | -16.94% | 8.69 | 0.0% | $1041.81m | |
| NVAX | Novavax, Inc. | -13.19% | 159.40 | 92.9% | $626.12m | |
| AMGN | Amgen, Inc. | -0.61% | 222.58 | 1.3% | $545.63m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.28% | 207.85 | 1.9% | $517.40m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.54% | 444.32 | 2.7% | $500.47m | |
| GILD | Gilead Sciences, Inc. | 1.48% | 63.68 | 1.0% | $487.18m | |
| ILMN | Illumina, Inc. | -4.00% | 399.75 | 3.5% | $457.42m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.28% | 147.78 | 2.0% | $340.58m | |
| BIIB | Biogen, Inc. | -1.10% | 263.68 | 1.7% | $316.91m | |
| CRSP | CRISPR Therapeutics AG | -5.82% | 112.15 | 0.6% | $266.47m | |
| BNGO | Bionano Genomics, Inc. | -19.71% | 6.87 | 0.0% | $242.96m | |
| EXAS | EXACT Sciences Corp. | -5.96% | 119.03 | 18.4% | $221.98m | |
| SGEN | Seagen Inc. | -1.99% | 144.99 | 5.8% | $204.86m | |
| PACB | Pacific Biosciences of California, Inc. | -8.57% | 28.31 | 7.2% | $149.78m |
Company Profile
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.